openPR Logo

Press Releases from Coherent Market Insights - Biotechnology (449 total)

Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …

Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used

Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …

Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness

Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …

The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

Diabetes Vaccine Market Scrutinized in New Research 2018-2026

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Diabetes vaccine is being developed to strengthen the body’s response against enterovirus

Oral Biologics Market Perspective by Comprehensive Analysis, Growth Prediction t …

The global oral biologics market size was valued at US$ 834.3 Mn in 2018, and is expected to witness a CAGR of 32.8% during the forecast period (2018 – 2026). Biological drugs refer to therapeutic products derived from living organisms or contain components of living organisms. Biological drugs are widely used in the treatment of number of diseases including diabetes, plaque psoriasis, arthritis, Crohn’s disease, and ulcerative colitis. Oral biologics products

Global B-cell Maturation Antigen (BCMA) Targeted Therapies Market Revenue Growth …

Recurrence of multiple myeloma has been a highly prevalent health condition, which requires novel and effective immunotherapeutic treatment. According to Leukemia Research by Elsevier, as of 2014, the incidence of multiple myeloma is estimated to be around 120,000 cases per year, with a global prevalence of over one million cases. B-cell maturation antigen (BCMA), is a cell surface protein that is expressed on the malignant plasma cells. This cell surface

Organ Transplant Market Poised to Garner Maximum Revenues During 2018 – 2026 W …

Organ transplantation is the surgical operation carried out for replacement of damaged or not functional organ of an individual. Donated organ are obtained from living donor, deceased donor or from an animal. Whereas in some cases an artificial organ is used for the transplantation procedure. The most common organ transplant includes kidney, heart, liver, pancreas, lung, and intestine. Double organ transplantation is also possible such as kidney and pancreas transplant

Non-Insulin Therapies for Diabetes Market Is Thriving According To New Report: O …

Non-insulin therapies are mostly used in type 2 diabetes patients, where body either does not produce enough insulin or is unable to effectively use the insulin it produces. Non-insulin-based medication works with different mechanism of action to reduce blood glucose level and maintain it for optimum glycemic control. For instance, some agents increase the insulin release from pancreatic cells (Sulfonylureas), some agents increase glucose uptake by periphery and reduces hepatic

Immunostimulatory Adjuvants Market to Perceive Substantial Growth During 2018– …

Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature. Various molecules have been considered for use as an adjuvant, such as mineral salts, oil emulsions, microbial

Oral Biologics Market : Frequent Research is Serving To Cause The Growth Till 20 …

The global oral biologics market size was valued at US$ 834.3 Mn in 2018, and is expected to witness a CAGR of 32.8% during the forecast period (2018 – 2026). Biological drugs refer to therapeutic products derived from living organisms or contain components of living organisms. Biological drugs are widely used in the treatment of number of diseases including diabetes, plaque psoriasis, arthritis, Crohn’s disease, and ulcerative colitis. Oral biologics

Natural Killer Cells Market Evolving Industry Trends and key Insights by 2026 Wi …

Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent

Single Cell Genome Sequencing Market Clinical Review, Analysis And Synthesis 201 …

Single cell genome sequencing involves isolating a single cell and amplifying and sequencing genes within that single cell. Sequencing single cell carries significant importance as individual cells can differ at great extent in size, protein levels, and expressed RNA transcripts. These variations could provide important insights about several research applications such as cancer research, stem cell biology, immunology, developmental biology, and neurology. Single-cell analysis enables a closer view of the

Artificial Pancreas Device System (APDS) Market Is Growing Exponentially In Orde …

The global artificial pancreas device system (APDS) market was valued at US$ 64.0 million in 2015 and is expected to witness a moderate CAGR of 18.6% during the forecast period (2016 – 2024). Eating habits of type 1 diabetes patients is highly curtailed, complemented by regular administration of insulin. Type 1 diabetes patients require multiple doses of insulin in a day and all-round the year. Advancements in research and technology

Immunostimulatory Adjuvants Market Projected to witness a Single Digit CAGR duri …

Adjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity. Adjuvants are used to enhance efficiency of vaccines as conventional vaccines are highly reactogenic in nature. Various molecules have been considered for use as an adjuvant, such as mineral salts, oil emulsions, microbial

Stem Cell Banking Market Headed for Growth and Global Expansion by 2026 With Top …

The global stem cell banking market was valued at US$ 1,634.7 million in 2016 and is expected to exhibit a robust CAGR of 18.9% over the forecast period (2017–2025). Stem cells have the potential to transform to any tissue or organ in the body. Stem cells can be found in bone marrow, fetal tissues, baby teeth, fat, human embryos, hair follicles, muscle, and circulating blood, however, cord blood is an

Diabetes Vaccine Market: Adoption of Innovative Offerings to Boost Returns on In …

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Diabetes vaccine is being developed to strengthen the body’s response against enterovirus

Single Cell Genome Sequencing Market Progresses for Huge Profits in Biotechnolog …

Single cell genome sequencing involves isolating a single cell and amplifying and sequencing genes within that single cell. Sequencing single cell carries significant importance as individual cells can differ at great extent in size, protein levels, and expressed RNA transcripts. These variations could provide important insights about several research applications such as cancer research, stem cell biology, immunology, developmental biology, and neurology. Single-cell analysis enables a closer view of the

Oral Biologics Market Necessity And Demand 2019 to 2026 With Key Companies Novo …

The global oral biologics market size was valued at US$ 834.3 Mn in 2018, and is expected to witness a CAGR of 32.8% during the forecast period (2018 – 2026). Biological drugs refer to therapeutic products derived from living organisms or contain components of living organisms. Biological drugs are widely used in the treatment of number of diseases including diabetes, plaque psoriasis, arthritis, Crohn’s disease, and ulcerative colitis. Get The PDF

Stem Cell Banking Market Headed for Growth and Global Expansion by 2026 With Top …

The global stem cell banking market was valued at US$ 1,634.7 million in 2016 and is expected to exhibit a robust CAGR of 18.9% over the forecast period (2017–2025). Stem cells have the potential to transform to any tissue or organ in the body. Stem cells can be found in bone marrow, fetal tissues, baby teeth, fat, human embryos, hair follicles, muscle, and circulating blood, however, cord blood is an

Diabetes Vaccine Market: Latest Advancements & Market Outlook 2018 to 2026

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Diabetes vaccine is being developed to strengthen the body’s response against enterovirus

Natural Killer Cells Market: Deep Analysis by Production Overview and Insights 2 …

Natural killer cells are a form of granular lymphocytes of varying sizes that play an important role in innate immunity in the human body. They typically constitute of around 10% of total blood lymphocytes as compared to around 70% and 20% of T cells and B cells, respectively. Natural killer cells are cytotoxic in nature and are able to kill their targets cells by two different mechanisms: as antibody dependent

Porcine Vaccines Market Size & Share to See Modest Growth Through 2026 By Key Pl …

Vaccines are the most imperative mediations for disease control among animals and humans. Under veterinary pharmaceuticals, vaccination is considered as a windfall for maintaining animal health by preventing spread of several endemic diseases. Such diseases which can be endemic are porcine reproductive and respiratory virus (PRRSV), swine influenza, diarrhea, porcine circovirus associated disease (PCVAD). Furthermore, cholera, high fever, foot and mouth diseases in swine have been significantly eliminated in North

Diabetes Vaccine Market: Deep Analysis by Production Overview and Insights 2018- …

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age group (Below 20 years age), who are characterized by a stronger autoimmune response to combat infection from specific viruses. Download The PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1367 Diabetes vaccine is

Pediatric Vaccines Market Estimated to Record Highest CAGR by 2026 With Top Key …

The global pediatric vaccines market was valued at US$ 23,317.0 million in 2017 and is expected to witness a CAGR of 10.8% over the forecast period (2018 – 2026). Pediatric vaccines are revolutionizing the healthcare industry by providing protection against the severe illnesses, thereby enabling improved heath and reduced family stress. Moreover, childhood immunization is essential step in maintaining high vaccination levels within the population, which prevents outbreaks such as

CRISPR and CAS Gene Market: Future and Technological Advancement 2026 With Top K …

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) genes are essential for the adaptive immunity in few bacteria and archaea, enabling the organisms to respond to and to eliminate invading genetic material. These gene editing tools are extensively used in agriculture and food security. Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2598 Many food and agricultural organizations are working on receiving license for using CRISPR and CAS gene technology

Antibodies Market Advancements to Watch Out For 2026 By Top Key Players BioLegen …

Antibodies, are also known as an immunoglobulins, are large Y-shaped proteins that are produced by specialized white blood cells (B-lymphocytes). Major function of antibodies is to neutralize the pathogens such as pathogenic bacteria and viruses. Immunoglobulins are classified into five classes on the basis of their constant region, namely IgG, IgM, IgD, IgA, and IgE. Antibodies market covers the product such as monoclonal antibodies and polyclonal antibodies, and has applications

Biomarkers Market: Latest Advancements & Market Outlook 2018 to 2026 With Top Ke …

The biomarkers market is estimated to be valued at US$ 29,518.2 Mn in 2017 and is expected to witness a robust CAGR of 13.6% during the forecast period (2017-2025). Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in

Biosimilars Market Summit to Showcase New Innovations from Leading Manufacturing …

The global biosimilars market size was valued at US$ 5.0 billion in 2017, and is expected to witness a CAGR of 35.2% over the forecast period (2018 – 2026). Biosimilars are biopharmaceutical drugs that have active components and are similar to the drugs, which have been previously licensed. They are identical copies of the original product and can be manufactured only when the patent for the original innovator product expires.

Targeted Cancer Therapies Market: Moving Towards a Brighter Future 2018-2026 By …

Targeted cancer therapies are drugs which block the growth and proliferation of cancer by interfering with specific molecules such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. Targeted cancer therapies differ in several ways from standard chemotherapy. Standard chemotherapy act on all rapidly dividing cancerous cells as well as normal cells, while targeted cancer therapies act on specific molecular targets that are associated

Viral Vector and Plasmid DNA Manufacturing Market To Grow Like Never Before By 2 …

The global viral vector and plasmid DNA manufacturing market size was valued at US$ 290.0 million in 2017, and is expected to exhibit a CAGR of 22.5% over the forecast period (2018 – 2026). Viral vector and plasmid DNA is product of gene therapy, which is used in diagnosis and treatment of diseases such as cancer, inherited diseases, viral infections, and others. The therapeutic DNA is introduced in host with

Cell Cryopreservation Market Perspective by Comprehensive Analysis Growth Predic …

Cryopreservation is a technique used to preserve various cells, tissue, organelles, and other biological products by cooling them at very low temperatures. Cryopreservation uses very low temperatures to preserve structurally intact living cells and tissues for a prolonged time period. Stem cells and various valuable tissues used in research studies and many other medical application are preserved by cryopreservation, as they cannot be stored by simple cooling for a long

Recombinant DNA Technology Market Value Projected to Expand by 2018-2026 With Ke …

The global recombinant DNA technology market was valued at US$ 106.8 billion in 2017, and is expected to exhibit a robust CAGR of 7.9% over the forecast period (2017 – 2025). Rapid technological advancements in the field of genetic engineering to deliver highly efficient therapeutics for disease management and in the field of agriculture are major driving factors for growth of recombinant DNA technology market. Download PDF Brochure of This

Targeted Cancer Therapies Market Advancements to Watch Out For 2026 And The Top …

Targeted cancer therapies are drugs which block the growth and proliferation of cancer by interfering with specific molecules such as DNA or proteins, which are involved in the growth or expansion of cancerous cells. Targeted cancer therapies differ in several ways from standard chemotherapy. Standard chemotherapy act on all rapidly dividing cancerous cells as well as normal cells, while targeted cancer therapies act on specific molecular targets that are associated

Viral Vector and Plasmid DNA Manufacturing Market Enhancement in Medical Sector …

Increasing prevalence of cancer is a major factor driving growth of the viral vector and plasmid DNA manufacturing market. According to World Cancer Research Funds and the American Institute for Cancer Research, in 2018, there were around 18 million cases of cancer, of which around 9.5 million were in men and around 8.5 million in women, globally. Moreover, government and other organizations’ initiatives regarding awareness of gene is expected to

Hematopoietic Stem Cell Transplantation (HSCT) Market To Reflect Significant Inc …

Rising incidence of leukemia and lymphoma and continuous research on hematopoietic stem cells are expected to drive market growth As per 2017 report by Leukemia and Lymphoma Society, the U.S. alone is expected to account for a prevalence of 8,16,834 and incidence of 80,500 for lymphoma. Increasing rate of incidence is in turn, expected to increase the demand for hematopoietic stem cell transplantation thus, propelling growth of the hematopoietic stem cell

Genome Engineering Market Value Projected to Expand During 2018-2026 With Key Pl …

The global genome engineering market was valued at US$ 2,582.7 Mn in 2016 and is expected to witness a CAGR of 14.3% over the forecast period (2017–2025). Genome engineering is a technique in which a DNA is inserted, deleted, modified or replaced in the genome of a living organism. Research and development activities are conducted in genome engineering for the development of novel technologies. For instance, in 2017, Synthego Corporation

Biomarkers Market Effect and Growth Factors Research and Projection 2018-2026 Wi …

Biomarkers are used for diagnosis and drug development, as these biomarkers can indicate diseases in the body. Furthermore, biomarkers can be any specific cells, molecules, genes or gene products, enzymes or hormones. Biomarker-based test are precise and rapid, which help in early prediction of susceptibility, prognosis, diagnosis, and treatment of disease. Hence, increasing research and development activities for identifying new biomarkers to diagnose or treat diseases is expected to be

Insulin Biosimilars Market Best Productivity Supply Chain Relationship, Developm …

Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million

Future Growth of Subcutaneous Biologics Market | Top Key Players – Amgen, Inc. …

In terms of geography, the global market for subcutaneous biologics is segmented into four major regions, namely, North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). There is huge healthcare spending in countries such as United States and Canada, and high prevalence of diseases such as rheumatoid arthritis and breast cancer. The Centers for Disease Control and Prevention (CDC) estimate that the current prevalence of rheumatoid arthritis (nearly

Biomarker Research Services Market Perspective by Comprehensive Analysis Growth …

The global biomarker research services market size was valued at US$ 5,897.7 million in 2017, and is expected to witness a robust CAGR of 13.5% over the forecast period (2018–2026). Biomarkers are widely used in development of drugs. One of the primary processes through which biomarkers are accepted for use in drug development, is the drug approval process. Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2612 The biomarker is included

Tuberculosis Vaccine Market - Opportunity Analysis By Top Key Players: GlaxoSmit …

Tuberculosis account for the highest amount of death caused due to infectious disease across the globe. According to the World Health Organization (WHO) factsheet 2018 on TB, 10.4 million people fell ill with TB in 2016 and 1.7 million people with TB died in the same year. More than 95% of TB deaths occur in low- and middle-income economies. Deaths caused due to TB also includes death of 0.4 million

Peptide Cancer Vaccine Market - Global Insights By Leading Players: TapImmune, M …

Increasing prevalence of cancer and failure of conventional methods to treat the disease effectively have led to increasing demand for new immunotherapy-based therapy such as peptide vaccine. According to a National Cancer Institute, 2016, in the U.S., it was estimated that 16.8 million new cases of cancer were diagnosed with an approximate 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million

Cell Processing Market Overview, Manufacturing Cost Structure Analysis by Top Ke …

The global cell processing market size is expected to increase, owing to rising demand for cell therapy. Cell therapy is the only curative treatment for many diseases such as cancer, autoimmune disease, and neural disease. According to the Worldwide Network for Blood and Marrow Transplantation (WBMT), in 2012, around one million stem cell transplantations were performed, worldwide. Get PDF Sample Copy of this Report @ www.coherentmarketinsights.com/insight/request-sample/2518 Continuous research and development for

Monoclonal Antibody Therapeutics Market Is Witnessing High Growth By Leading Pla …

Monoclonal antibody therapeutics market is driven by active research and development of novel drugs and significant number of new drug launches and approval. There are number of monoclonal antibodies in the pipeline, which are expected to receive approval over the forecast period. For instance, manufacturers such as Amgen, Inc., Novartis International AG, Merck & Co., Inc., Eily, Lilly, and Company, and others have several monoclonal antibodies in the pipeline. Ask

Cell and Gene Therapy Market - Rich Product Pipeline Analysis and In-depth Resea …

According to the World Cancer Research Funds and the American Institute for Cancer Research, in 2018, there were around 18 million cases of cancer, of which around 9.5 million were in men and around 8.5 million in women, globally. Moreover, introduction of innovative products and rich pipeline of cell and gene therapy is expected to boost the market growth. For instance, around 150 gene therapies are currently in the development

Pharmacogenomics Market Analysis and In-depth Research on Thermo Fisher Scientif …

Major factors that propel the market are increasing demand for personalized drugs, increasing prevalence of several non-infectious and infectious diseases, rising utilization of these technology for effective treatment therapeutics, and growing awareness about benefits associated with pharmacogenomics. Continuous collaboration among pharmacogenomics manufacturers for various applications in clinical and translational research is also expected to drive growth of the market across regions. In 2016, Merck & Co. Inc., collaborated with Biocartis,

Biopharmaceuticals and Biomedicine Market Key Findings with Worldwide Top Compan …

Global Biopharmaceutical and Biomedicine Market, By Product Type (Biopharmaceutical, Nanomedicine, Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), By Application (Therapeutics, Diagnostics, and Research and Development) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 358.4 Bn in 2016 and is projected to exhibit a CAGR of 9.4% over the forecast period (2017–2025), as highlighted in a new report published

Cancer Biomarkers Market Impressively growing Opportunities with Top Players Bio …

The Global Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer, and Others), by End User (Hospitals, Academic and Cancer Research Institutes, Ambulatory Surgical Centers, and Diagnostic Laboratories), was valued US$ 33.7 billion in 2017 and is projected to exhibit a CAGR of 14.2% over the forecast period (2017–2025) as highlighted in a new

Viral Vectors and Plasmid DNA Manufacturing Market Key Developments, Footprint w …

Viral vector and plasmid DNA manufacturing plays a major role in modern healthcare, as it reduces disease management price by generating a wider range of immune response types and supporting to decrease the periodic medication dosage. The global viral vector and plasmid DNA manufacturing market size was valued at US$ 290.0 million in 2017, and is expected to exhibit a CAGR of 22.5% over the forecast period (2018 – 2026). Viral vector

Insulin Biosimilars Market Latest Trends By Top Companies Pfizer, Biocon, Merck, …

Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million

Go To Page: 1 3 4 5 6 7 8 9